Treatment of fragile x syndrome with cannabidiol
AssigneeHarmony Biosciences Management, Inc.
InventorsJoseph Palumbo, Stephen V. O'Quinn, Terri Sebree, Marcel Bonn-Miller, Donna Gutterman
Life of this patent
Estimating the term…
Abstract
The present technology relates to a method of treating one or more behavioral symptoms of autism spectrum disorder (ASD) in a subject by administering an effective amount of cannabidiol (CBD). Specifically, subjects having moderate to severe ASD and relatively high social avoidance and/or anxiety are more likely to show a reduction in irritability when treated with CBD.
Claims15
A method of treating a human suffering from moderate to severe autism spectrum disorder comprising transdermally administering via a gel or cream a therapeutically effective amount of purified cannabidiol to the human suffering from the autism spectrum disorder to effectively treat the autism spectrum disorder in the human in need thereof, wherein the gel or cream is administered to the upper arm.
Dependencies are inferred from the claim text.